Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Celery extract is derived from the seeds or other parts of the Apium graveolens plant. It has been traditionally used for its purported anti-inflammatory, antioxidant, antimicrobial, and diuretic properties. The main bioactive components include 3-n-butylphthalide and various flavonoids such as luteolin. Celery extract has been studied for potential benefits in conditions like hypertension (notably reducing blood pressure), anxiety and depression (as an adjunct in hypertensive patients), arthritis (antiarthritic effects), gout, and digestive complaints. Mechanistically, it may suppress proinflammatory cytokines and inhibit nitric oxide production; some extracts have shown activity against certain bacteria including Helicobacter pylori[1][3][7]. However, robust clinical evidence supporting these uses is limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on celery extract.